Log in

NASDAQ:VTVTvTv Therapeutics News Headlines

$1.74
-0.05 (-2.79 %)
(As of 04/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.68
Now: $1.74
$1.80
50-Day Range
$1.63
MA: $2.55
$3.75
52-Week Range
$1.23
Now: $1.74
$4.23
Volume59,400 shs
Average Volume837,737 shs
Market Capitalization$113.56 million
P/E RatioN/A
Dividend YieldN/A
Beta-2.41

Headlines

vTv Therapeutics (NASDAQ VTVT) News Headlines

Source:
DateHeadline
vTv Therapeutics IncvTv Therapeutics Inc
www.bloomberg.com - March 24 at 9:18 PM
vTv Therapeutics (NASDAQ:VTVT) Rating Reiterated by HC WainwrightvTv Therapeutics (NASDAQ:VTVT) Rating Reiterated by HC Wainwright
www.americanbankingnews.com - March 18 at 9:23 AM
Has vTv Therapeutics (VTVT) Outpaced Other Medical Stocks This Year?Has vTv Therapeutics (VTVT) Outpaced Other Medical Stocks This Year?
finance.yahoo.com - March 12 at 1:42 PM
100 Stocks Moving In Thursdays Mid-Day Session100 Stocks Moving In Thursday's Mid-Day Session
feeds.benzinga.com - February 27 at 12:54 PM
vTv Therapeutics Inc. (VTVT) Shares March Higher, Can It Continue?vTv Therapeutics Inc. (VTVT) Shares March Higher, Can It Continue?
finance.yahoo.com - February 24 at 2:07 PM
vTv Therapeutics EPS misses by $0.08vTv Therapeutics EPS misses by $0.08
seekingalpha.com - February 21 at 8:31 AM
vTv Therapeutics Announces 2019 Fourth Quarter and Full Year Financial Results and Provides Corporate UpdatevTv Therapeutics Announces 2019 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
finance.yahoo.com - February 20 at 11:51 PM
VTV Therapeutics Close To The Finish Line On What FDA, Diabetes Patients Want: An Adjunct Therapy To InsulinVTV Therapeutics 'Close To The Finish Line' On What FDA, Diabetes Patients Want: An Adjunct Therapy To Insulin
www.msn.com - February 19 at 1:27 PM
vTv Therapeutics: A Promising Small Molecule Drug Discovery Pick For 2020vTv Therapeutics: A Promising Small Molecule Drug Discovery Pick For 2020
seekingalpha.com - February 17 at 1:19 PM
Catalyst Biosciences Results Positive, And Other News: The Good, Bad And Ugly Of BiopharmaCatalyst Biosciences Results Positive, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - February 11 at 2:00 PM
vTv Therapeutics (NASDAQ: VTVT)vTv Therapeutics (NASDAQ: VTVT)
www.benzinga.com - February 10 at 5:42 PM
Mid-Afternoon Market Update: Dow Rises 70 Points; vTv Therapeutics Shares JumpMid-Afternoon Market Update: Dow Rises 70 Points; vTv Therapeutics Shares Jump
feeds.benzinga.com - February 10 at 3:33 PM
TSLA, INO among premarket gainersTSLA, INO among premarket gainers
seekingalpha.com - February 10 at 12:42 PM
8 Biotechnology Stocks Moving In Mondays Pre-Market Session8 Biotechnology Stocks Moving In Monday's Pre-Market Session
www.benzinga.com - February 10 at 12:42 PM
VTV Therapeutics Shares Hit 16-Month High After Diabetes Drug Aces Midphase StudyVTV Therapeutics Shares Hit 16-Month High After Diabetes Drug Aces Midphase Study
www.benzinga.com - February 10 at 12:42 PM
Vtv Therapeutics up 67% premarket on positive TTP399 dataVtv Therapeutics up 67% premarket on positive TTP399 data
seekingalpha.com - February 10 at 7:41 AM
vTv Therapeutics Announces Positive Results from Part 2 of the Phase 2 Simplici-T1 Study of TTP399, Potential First-in-Class Oral Adjunctive Therapy for Patients with Type 1 DiabetesvTv Therapeutics Announces Positive Results from Part 2 of the Phase 2 Simplici-T1 Study of TTP399, Potential First-in-Class Oral Adjunctive Therapy for Patients with Type 1 Diabetes
finance.yahoo.com - February 10 at 7:41 AM
VTv Therapeutics up 21% after hours ahead of key data readoutVTv Therapeutics up 21% after hours ahead of key data readout
seekingalpha.com - February 7 at 8:03 PM
vTv Therapeutics to Host Investor Call and Announce Results from Part 2 of the Phase 2 Simplici-T1 Study of TTP399 – Potential First-in-Class Oral Adjunctive Therapy for Patients with Type 1 DiabetesvTv Therapeutics to Host Investor Call and Announce Results from Part 2 of the Phase 2 Simplici-T1 Study of TTP399 – Potential First-in-Class Oral Adjunctive Therapy for Patients with Type 1 Diabetes
finance.yahoo.com - February 7 at 8:03 PM
VTv Therapeutics +7% as Perelman boosts stakeVTv Therapeutics +7% as Perelman boosts stake
seekingalpha.com - January 7 at 8:43 PM
15 storylines to watch in the '20s: Oasis in the Triad15 storylines to watch in the '20s: Oasis in the Triad
finance.yahoo.com - January 3 at 10:24 AM
High Point company to complete Phase 2 of Alzheimer’s study by 2021High Point company to complete Phase 2 of Alzheimer’s study by 2021
www.msn.com - December 23 at 7:23 PM
vTv Therapeutics to complete Phase 2 of Alzheimer’s study by 2021vTv Therapeutics to complete Phase 2 of Alzheimer’s study by 2021
finance.yahoo.com - December 19 at 8:00 AM
Executive chairman of vTv Therapeutics resignsExecutive chairman of vTv Therapeutics resigns
finance.yahoo.com - December 2 at 8:55 AM
vTv Therapeutics to Present at the 31st Annual Piper Jaffray Healthcare ConferencevTv Therapeutics to Present at the 31st Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - December 2 at 8:55 AM
vTv Therapeutics EPS misses by $0.07vTv Therapeutics EPS misses by $0.07
seekingalpha.com - October 30 at 10:26 PM
VTv Therapeutics (VTVT) Reports Q3 Loss, Misses Revenue EstimatesVTv Therapeutics (VTVT) Reports Q3 Loss, Misses Revenue Estimates
finance.yahoo.com - October 30 at 10:26 PM
vTv Therapeutics (Class A)vTv Therapeutics (Class A)
www.fool.com - October 23 at 1:48 PM
VTVT.A - vTv Therapeutics Inc Profile | ReutersVTVT.A - vTv Therapeutics Inc Profile | Reuters
www.reuters.com - October 7 at 8:18 AM
vTv to Host Key Opinion Leader Event to Discuss the Type 1 Diabetes Treatment Landscape and Emerging Therapies as Adjuncts to InsulinvTv to Host Key Opinion Leader Event to Discuss the Type 1 Diabetes Treatment Landscape and Emerging Therapies as Adjuncts to Insulin
finance.yahoo.com - October 3 at 5:20 PM
Vtv Therapeutics up 5% premarket on positive TTP399 dataVtv Therapeutics up 5% premarket on positive TTP399 data
seekingalpha.com - September 18 at 10:48 AM
vTv Therapeutics Presents Additional Positive Data from the Phase 2 Simplici-T1 Study in Patients with Type 1 Diabetes at 55th Annual Meeting of the European Association for the Study of DiabetesvTv Therapeutics Presents Additional Positive Data from the Phase 2 Simplici-T1 Study in Patients with Type 1 Diabetes at 55th Annual Meeting of the European Association for the Study of Diabetes
finance.yahoo.com - September 18 at 10:48 AM
Biotech Stock On The Radar: vTv Therapeutics Diabetes PipelineBiotech Stock On The Radar: vTv Therapeutics' Diabetes Pipeline
feeds.benzinga.com - September 17 at 5:12 PM
vTv Therapeutics’ largest holder purchases $1 million in sharesvTv Therapeutics’ largest holder purchases $1 million in shares
www.bizjournals.com - September 14 at 4:31 PM
vTv Therapeutics to Present Posters at Two Scientific Conferences in SeptembervTv Therapeutics to Present Posters at Two Scientific Conferences in September
finance.yahoo.com - September 11 at 2:43 PM
Thursday 9/5 Insider Buying Report: YEXT, VTVTThursday 9/5 Insider Buying Report: YEXT, VTVT
www.nasdaq.com - September 5 at 11:13 AM
vTv Therapeutics to Present at the H.C. Wainwright 21st Annual Global Investment ConferencevTv Therapeutics to Present at the H.C. Wainwright 21st Annual Global Investment Conference
finance.yahoo.com - September 4 at 11:51 AM
Largest Insider Trades of the WeekLargest Insider Trades of the Week
finance.yahoo.com - August 30 at 11:49 PM
Wednesday 8/7 Insider Buying Report: VTVT, DOWWednesday 8/7 Insider Buying Report: VTVT, DOW
www.nasdaq.com - August 7 at 10:41 PM
vTv Therapeutics to Participate in Upcoming Canaccord Genuity and Solebury Trout Conferences vTv Therapeutics to Participate in Upcoming Canaccord Genuity and Solebury Trout Conferences 
finance.yahoo.com - August 7 at 5:38 PM
vTv Therapeutics Announces 2019 Second Quarter Financial Results and UpdatevTv Therapeutics Announces 2019 Second Quarter Financial Results and Update
finance.yahoo.com - July 31 at 5:44 PM
VTv Therapeutics to present at Alzheimers conference; shares +8.8%VTv Therapeutics to present at Alzheimer's conference; shares +8.8%
seekingalpha.com - July 16 at 9:49 AM
vTv Therapeutics to Present at 2019 Alzheimer’s Association International ConferencevTv Therapeutics to Present at 2019 Alzheimer’s Association International Conference
finance.yahoo.com - July 15 at 5:38 PM
vTvs majority stockholder to sell 16.45M sharesvTv's majority stockholder to sell 16.45M shares
seekingalpha.com - July 5 at 5:17 PM
Mid-stage study underway for vTvs azeliragon in Alzheimers and T2D; shares up 8% after hoursMid-stage study underway for vTv's azeliragon in Alzheimer's and T2D; shares up 8% after hours
seekingalpha.com - June 27 at 5:34 PM
Wednesday 6/26 Insider Buying Report: AKRO, VTVTWednesday 6/26 Insider Buying Report: AKRO, VTVT
www.nasdaq.com - June 27 at 9:45 AM
VTv Therapeutics: Unreasonably CheapVTv Therapeutics: Unreasonably Cheap
seekingalpha.com - June 7 at 5:32 PM
vTv Therapeutics Reports Positive Midstage Trial Results For Type 1 Diabetes DrugvTv Therapeutics Reports Positive Midstage Trial Results For Type 1 Diabetes Drug
www.benzinga.com - June 6 at 5:49 PM
vTv Therapeutics Announces Positive Topline Results from Part 1 of the Phase 2 Simplici-T1 Trial in Patients with Type 1 DiabetesvTv Therapeutics Announces Positive Topline Results from Part 1 of the Phase 2 Simplici-T1 Trial in Patients with Type 1 Diabetes
finance.yahoo.com - June 6 at 9:36 AM
Biotech entrepreneur seeks approval of 80-acre Triad R&D campus with 1,600 jobsBiotech entrepreneur seeks approval of 80-acre Triad R&D campus with 1,600 jobs
finance.yahoo.com - May 29 at 6:01 PM
This page was last updated on 4/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel